# DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins

> **NCT07298083** · — · RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 60 (estimated)

## Conditions studied

- Neurofibromas
- MPNST

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07298083
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-02
- **Primary completion:** 2030-04-30
- **Final completion:** 2032-04-20
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07298083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07298083, "DoD Award NF230020 Identification of Metabolic Markers and Statistical Prediction of MPNST for Rapid Diagnosis and Assessment of Surgical Margins". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07298083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*